Edition:
India

Sino Biopharmaceutical Ltd (1177.HK)

1177.HK on Hong Kong Stock

7.07HKD
22 Nov 2018
Change (% chg)

HK$-0.37 (-4.97%)
Prev Close
HK$7.44
Open
HK$7.44
Day's High
HK$7.44
Day's Low
HK$7.07
Volume
50,520,399
Avg. Vol
62,282,846
52-wk High
HK$13.93
52-wk Low
HK$6.03

Latest Key Developments (Source: Significant Developments)

Sino Biopharmaceutical Posts 9-Mth Revenue Of RMB15,730.16 Mln, Up 37.4 Pct
2:05pm IST 

Nov 22 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::9-MONTH REVENUE RMB15,730.16 MILLION, UP 37.4 PERCENT.DECLARED PAYMENT OF A THIRD QUARTERLY DIVIDEND OF HK2 CENTS PER SHARE.9-MONTH PROFIT ATTRIBUTABLE RMB2,201.26 MILLION, UP 22.0%.  Full Article

Sino Biopharmaceutical Says Unit's Product Obtains Approval For Drug Registration
Wednesday, 31 Oct 2018 

Oct 31 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::MOXIFLOXACIN HYDROCHLORIDE AND SODIUM CHLORIDE INJECTION OBTAINS APPROVAL FOR DRUG REGISTRATION.APPROVAL GRANTED BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF PEOPLE'S REPUBLIC OF CHINA.  Full Article

Sino Biopharmaceutical Says Trustee Further Purchased Shares Of Co For Total Consideration Of HK$48.6 Million
Wednesday, 12 Sep 2018 

Sept 12 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::TRUSTEE FURTHER PURCHASED 6.5 MILLION SHARES OF CO FOR TOTAL CONSIDERATION OF HK$48.6 MILLION.  Full Article

Sino Biopharmaceutical Posts HY Profit Attributable Of RMB1,365.67 Mln
Wednesday, 22 Aug 2018 

Aug 22 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::HY REVENUE RMB9,725.23 MILLION, UP 30.0%.H1 PROFIT ATTRIBUTABLE RMB1,365.67 MILLION 24.1% HIGHER.DECLARED PAYMENT OF A SECOND QUARTERLY DIVIDEND OF HK2 CENTS PER SHARE.  Full Article

Sino Biopharmaceutical Announces Passing Of EU GMP Certification For Tenofovir Production Line
Wednesday, 1 Aug 2018 

Aug 1 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::ANNOUNCES PASSING OF EU GMP CERTIFICATION FOR TENOFOVIR PRODUCTION LINE.  Full Article

Sino Biopharmaceutical Says Obtained Drug Registration Approval For Bortezomib
Friday, 20 Jul 2018 

July 20 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::BORTEZOMIB FOR INJECTION OBTAINED APPROVAL FOR DRUG REGISTRATION BY NATIONAL DRUG ADMINISTRATION -PEOPLE'S REPUBLIC OF CHINA.  Full Article

Sino Biopharmaceutical Says Injection Obtained Drug Registration Approval By National Drug Administration
Wednesday, 27 Jun 2018 

June 27 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::DOCETAXEL INJECTION HAS OBTAINED APPROVAL FOR DRUG REGISTRATION BY NATIONAL DRUG ADMINISTRATION OF PEOPLE'S REPUBLIC OF CHINA.  Full Article

Sino Biopharmaceutical Says Trustee Purchased 5.1 Mln Shares Pursuant To Restricted Share Award Scheme
Friday, 1 Jun 2018 

June 1 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::FROM 23 MAY TO 1 JUNE , TRUSTEE PURCHASED 5.1 MILLION SHARES FROM MARKET TO HOLD ON TRUST FOR PARTICIPANTS FOR HK$97.4 MILLION.  Full Article

Sino Biopharmaceutical Posts Qtrly Net Profit Of RMB771.1 Mln
Friday, 18 May 2018 

May 18 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::QTRLY REVENUE WAS ABOUT RMB4,652.61 MILLION, UP 20.4%.QTRLY NET PROFIT RMB771.1 MILLION VERSUS RMB 579 MILLION.DECLARED PAYMENT OF A FIRST QUARTERLY DIVIDEND OF HK2 CENTS PER SHARE.  Full Article

Sino Biopharmaceutical Says Compound Sodium Acetate Ringer's Injection Gets Drug Registration Approvals
Wednesday, 2 May 2018 

May 2 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::COMPOUND SODIUM ACETATE RINGER'S INJECTION OBTAINS TWO APPROVALS FOR DRUG REGISTRATION BY CHINA FOOD AND DRUG ADMINISTRATION.  Full Article